Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-02 Sale | 2024-12-04 4:06 pm | BeiGene Ltd. | BGNE | HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner | 17,842,500 | $200 | $3,568,500,000 | 125,045,741 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-14 Exercise | 2024-12-17 5:02 pm | N/A N/A | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,300,000 | $0.5 | 59,140,096 (Direct) | View |
| 2024-12-14 Exercise | 2024-12-17 5:02 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,300,000 | $0 | 59,140,096 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:18 pm | N/A 2025-07-19 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 542,880 | $0 | 13,582,280 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-12 5:18 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 41,760 | $6.5 | 13,582,280 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-29 4:31 pm | N/A 2025-06-29 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 499,993 | $0 | 10,325,000 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-29 4:31 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 38,461 | $6.5 | 10,325,000 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 7:21 pm | N/A 2034-09-29 | BeiGene Ltd. | BGNE | Sharp Shalini Director | 25,389 | $0 | 25,389 (Direct) | View |
| 2024-08-12 Gift | 2024-08-14 5:27 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 301,457 | $0 | 10,453,563 (Direct) | View |
| 2024-08-09 Option Award | 2024-08-13 5:17 pm | N/A 2034-08-08 | BeiGene Ltd. | BGNE | Rosenberg Aaron Chief Financial Officer | 339,534 | $0 | 339,534 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:05 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Ball Titus B. Principal Accounting Officer | 39,767 | $0 | 63,245 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:04 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 730,795 | $0 | 1,762,600 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:03 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 487,188 | $0 | 2,145,403 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:03 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel | 282,880 | $0 | 454,194 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:02 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Dugan Margaret Director | 50,492 | $0 | 80,106 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:01 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director | 50,492 | $0 | 50,492 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:00 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director | 50,492 | $0 | 87,906 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:58 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,414,439 | $0 | 48,926,756 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:58 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Glazer Donald W. Director | 50,492 | $0 | 2,752,615 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:57 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 50,492 | $0 | 80,106 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:56 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 519,649 | $0 | 11,165,677 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:55 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director | 50,492 | $0 | 80,392 (Direct) | View |